NTT-COMMUNICATIONS
28.9.2020 08:02:09 CEST | Business Wire | Press release
NTT Communications Corporation (NTT Com), the ICT solutions and international communications business within the NTT Group (TOKYO:9432), announced today that beginning October 1 it will collaborate with the International Data Spaces Association (IDSA)1 in a demonstration test as the first phase of contributing to the development of a secure, global data-management platform2 that assures interoperability between data platforms built and managed in countries worldwide.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200927005006/en/
The test environment for sharing highly confidential data securely will include IDS Connectors3 , the core technology of GAIA-X4 , a federated data infrastructure for Europe, and NTT Com’s Things Cloud® IoT platform and Smart Data Platform (SDPF)5 , the later incorporating Data Trust®6 policies. The demonstration, in addition to assessing the practicality and operability of a new structure for appropriately controlling the access rights of each data based on related laws and contracts, will shed new light on the requirements, etc. of platforms designed for international data management. The results are expected to lead to the establishment of global data management platforms that smoothly link local data platforms in countries across the globe.
In the demonstration, a test environment will be built to test various cases of international data sharing, such as remote monitoring of machines overseas, etc., to verify the practicality and operability of data sharing. Initially, in collaboration with the NTT Software Innovation Center,7 IDS Connector and SDPF will be deployed in a test environment in Japan to test system interoperability and the management of specific data-usage rights. The test environment in Japan will then be connected to IDSA’s test environment in Germany and a separate test environment at the Swiss nonprofit Switzerland Innovation Park Biel/Bienne8 to test the system’s practicality and operability in controlling data access rights internationally via NTT Com’s networks.
Thereafter, NTT Com will proceed with further verification and testing by applying the current test’s findings in a test operation environment (test bed), aiming to verify the interoperability of various hardware and software using the IDS Connector. The new global data management platform will be jointly developed by Japanese and overseas companies and organizations. At the same time, NTT Com will determine concrete requirements for the platform together with various organizations and companies active in Japan and overseas, including the Robot Revolution & Industrial IoT Initiative.9 Going forward, NTT Com hopes to support the formulation of basic specifications through public-private-academic collaboration. Ultimately, NTT Com aims to contribute to the realization of a smart world by developing and providing a platform for broad sharing and usage of data in wide-ranging fields worldwide.
Technologies for IoT, artificial intelligence and data utilization are increasingly being applied in diverse fields, including manufacturing, logistics, transportation, medical care, energy, cities and government. To facilitate advanced, multipurposed data use, systems are needed to ensure the safe, reliable exchange of data among industries, businesses and countries. Simultaneously, the rights of data providers and users must be protected and observed by managing when, where, who, why and under what conditions specific data can be used. Currently, legal systems and technologies are being developed worldwide to create such data infrastructure. Eventually, data exchange in international business may require compliance with data-infrastructure specifications according to the laws and regulations of relevant countries.
1 |
The International Data Spaces Association (IDSA), originating in Europe, has defined a reference architecture and a formal standard to be used for creating and operating virtual data spaces. The International Data Spaces (IDS) Architecture is based on commonly accepted data governance models facilitating secure exchange and easy linkage of data within business ecosystems. IDSA counts over 120 member organizations from 21 countries. |
2 |
Global data-management platform is a function for mutually linking data platforms across borders so that each country can internationally distribute data safely, fairly and appropriately while protecting national assets and human rights. |
3 |
IDS Connector provided by IDSA is the core element of a data ecosystem designed to facilitate the secure exchange of data between trusted parties. Deployed in the GAIA-X infrastructure as well as in clouds, on edge computers or on devices, etc. that send and receive data, it provides settings for managing access to specific data based on laws and contracts. |
4 |
GAIA-X is an initiative announced by the German and French governments in October 2019 to build decentralized data infrastructure for data sharing and utilization protected by European data laws. |
5 |
Smart Data Platform (SDPF) is NTT Com’s next-generation platform that offers comprehensive, one-stop functions for corporate digital transformation (DX). |
6 |
DATA Trust® is a registered trademark of Nippon Telegraph and Telephone Corporation (NTT). |
7 |
The NTT Software Innovation Center is an NTT laboratory engaged in researching and developing IT infrastructure technologies, such as DX acceleration, software infrastructure, AI infrastructure and next-generation computers, that are becoming important infrastructure. |
8 |
Switzerland Innovation Park Biel/Bienne is a Swiss private nonprofit organization that carries out and supports primarily industry-oriented applied research and development. |
9 |
The Robot Revolution & Industrial IoT Initiative is a private organization established in 2015 at the initiative of the Japanese government to facilitate the use of industrial IoT, robots, etc. NTT Com has been active as the secretariat of the Global Data Management Platform Sub-Working group since October 2019. |
About NTT Communications
NTT Communications solves the world's technology challenges by helping enterprises overcome complexity and risk in their ICT environments with managed IT infrastructure solutions. These solutions are backed by our worldwide infrastructure, including industry leading, global tier-1 public and private networks reaching over 190 countries/regions, and more than 500,000m2
of the world's most advanced data center facilities. Our global professional services teams provide consultation and architecture for the resiliency and security required for your business success, and our scale and global capabilities in technology world are unsurpassed. Combined with NTT Ltd., NTT Data, and NTT DOCOMO, we are NTT Group.
www.ntt.com
| Twitter@NTT Com
| Facebook@NTT Com
| LinkedIn@NTT Com
View source version on businesswire.com: https://www.businesswire.com/news/home/20200927005006/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release
Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release
Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release
The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
